KeyBanc lowered the firm’s price target on Acadia Healthcare (ACHC) to $35 from $55 and keeps an Overweight rating on the shares. The firm expects a miss/lower given softer Q3 volumes; investors will be focused on a potential takeout/strategic alternatives. KeyBanc thinks $30-$40/share is a reasonable range in a takeout.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC: